Citadel Research and Solutions develops Covid-19 specific ventilator
Published on : Monday 27-04-2020
Indian engineering and innovation company Citadel Research and Solutions makes global breakthrough with ICoVent, Covid-19 specific ventilator.
Hyderabad, April 2020 – Mr Konda Vishweshwar Reddy, Engineer, Inventor, Entrepreneur and former Member of Indian Parliament, recently announced a global breakthrough with the development of ICoVent, a ‘rapidly manufacturable Covid-19 specific ventilator’. The ICoVent will help address the global shortage of ventilators. Speaking at the launch of the ICoVent, abbreviated for Indian Covid Ventilator, Mr Reddy said, “The successful development of this ventilator is testament to the capabilities of Indian engineering to solve global challenges. An original design that is conceptually new, the components used for manufacture of the ICoVent ventilator are freely available in most countries including India. Its precision does not depend on expensive sensors and regulators. The ICoVent, a rapidly manufacturable COVID-19 specific ventilator will help to bridge the shortfall and benefit humanity.”
With the COVID-19 pandemic, governments and healthcare systems suddenly found they needed more ventilators than they had to save the lives of patients. The UK was the first country to come out with a set of specifications defining 'the minimum clinically accepted criteria for a rapidly manufacturable ventilator to address the COVID-19 situation. The ICoVent meets the UK Government specifications. A patent for the technology and function has already been applied for. Citadel Research & Development Ltd is open to explore partnerships to manufacture in UK.
The ICoVent is specially designed for Covid-19 patients with ARDS which allows the doctor to precisely control volume and various pressures. All parameters like Peak Inspiration Pressure PIP, Plateau Pressure, PEEP, I:E Ratios, Tidal Volume, Modes, Triggers, etc., can be controlled in the ICoVent Ventilator.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)